Long

ImmunoPrecise Antibodies Stock Analysis

Quote: #IPA/#IPATF
Buy Target:$0.80/$0.60 (don’t bet the house here looking for a quick scalp)
Sell Target: $1.00
Description: ImmunoPrecise Antibodies Ltd. engages in antibody production and related services in the United States, Canada, and Europe. It also provides human antibody development, hybridoma development, genetic immunization, rabbit monoclonal antibody development, recombinant protein expression and production, cryostorage, hybridoma sequencing, antibody generation, antibody purification, polyclonal development, and peptide production services. The company has a collaboration agreement with TetraGenetics, Inc. The company was founded in 1989 and is based in Victoria, Canada.

Please follow us on our facebook and twitter. Subscribe to our newsletter to get analysis directly to your mail.
Facebook - SFYBUofficial
Twitter - @SFYBUoffical
fridayHarmonic Patternsmoneynasdaqnasdaq100nyseprofitsprofitsinfinityreviewtradeTrend AnalysisWave Analysis

Also on:

Disclaimer